Showing results (71-80 of 242) with videos related to
Sort By:
Pageof 25
Immunologic Research|July 11, 2025
Metabolic-associated enthesitis: a review on pathophysiology, clinical relevance, diagnostic challenges, and perspective on target treatmentsGiuseppe Lisco, Anna De Tullio, Roberta Zupo, et al.Plos One|April 25, 2013
Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosisElvira Favoino, Liboria Digiglio, Giovanna Cuomo, et al.Frontiers in Immunology|March 11, 2021
From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the PastMahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Afshin Derakhshani, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopesFederico Perosa, Elvira Favoino, Chiara Vicenti, et al.Blood|March 27, 2004
Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functionsMichelina Nascimbeni, Eui-Cheol Shin, Luis Chiriboga, et al.Current Problems in Cardiology|February 25, 2021
Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world SettingChiara Mozzini, Sebastiano Cicco, Angela Setti, et al.Frontiers in Immunology|March 1, 2024
Endothelial cells in tumor microenvironment: insights and perspectivesPatrizia Leone, Eleonora Malerba, Nicola Susca, et al.Arthritis Research & Therapy|July 11, 2013
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosisFederico Perosa, Elvira Favoino, Giovanna Cuomo, et al.Journal of Virology|March 31, 2006
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rulesVito Racanelli, Maria Antonia Frassanito, Patrizia Leone, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2017
Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B TherapeuticsTimothy M Block, Stephen Locarnini, Brian J McMahon, et al.Pageof 25